Next Article in Journal
Role of Real-World Evidence in Informing Cancer Care: Lessons from Colorectal Cancer
Previous Article in Journal
Adjuvant Therapy for Stages II and III Colon Cancer: Risk Stratification, Treatment Duration, and Future Directions
 
 
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Are We Finally Moving toward Personalized Therapy in Colorectal Cancer?

BC Cancer, Vancouver, 600 West 10th Avenue, BC V5Z 4E6, Canada
Curr. Oncol. 2019, 26(s1), 5-6; https://doi.org/10.3747/co.26.5943
Submission received: 13 August 2019 / Revised: 2 September 2019 / Accepted: 4 October 2019 / Published: 1 November 2019

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

Colorectal cancer (crc) will represent 12% of all new cancer cases and 12% of all cancer deaths in 2019, with more than 26,300 Canadians being diagnosed and 9500 Canadians dying of crc this year1.[...]

Share and Cite

MDPI and ACS Style

Gill, S. Are We Finally Moving toward Personalized Therapy in Colorectal Cancer? Curr. Oncol. 2019, 26, 5-6. https://doi.org/10.3747/co.26.5943

AMA Style

Gill S. Are We Finally Moving toward Personalized Therapy in Colorectal Cancer? Current Oncology. 2019; 26(s1):5-6. https://doi.org/10.3747/co.26.5943

Chicago/Turabian Style

Gill, S. 2019. "Are We Finally Moving toward Personalized Therapy in Colorectal Cancer?" Current Oncology 26, no. s1: 5-6. https://doi.org/10.3747/co.26.5943

APA Style

Gill, S. (2019). Are We Finally Moving toward Personalized Therapy in Colorectal Cancer? Current Oncology, 26(s1), 5-6. https://doi.org/10.3747/co.26.5943

Article Metrics

Back to TopTop